John Blakey|Bruce G. Bender|Alexandra L. Dima|John Weinman|Guilherme Safioti|Richard W. Costello
Digital technologies and adherence in respiratory diseases: the road ahead
Royal Liverpool University Hospital|University of Liverpool|National Jewish Health|University of Colorado Denver|Health Services and Performance Research Laboratory|Claude Bernard University Lyon 1|King's College London|Teva Pharmaceuticals (Netherlands)|Royal College of Surgeons in Ireland|Beaumont Hospital
outcomes patients chronic respiratory diseases remain poor despite development novel therapies part reflects fact adherence therapy low clinicians lack accurate methods assess issue digital technologies hold promise overcome barriers care example algorithmic analysis large amounts information collected health status treatment use along disease relevant information environmental data used help guide personalised interventions may positive health impact establishing habitual correct inhaler use novel approaches data analysis also offer possibility statistical algorithms better able predict exacerbations thereby creating opportunities preventive interventions may adapt therapy disease activity changes realise possibilities digital approaches disease management supported strong evidence solid infrastructure designed collaboratively clinically effective costeffective systems reflect needs patients healthcare providers regulatory standards digital interventions strategies handle large amounts data generated also needed review highlights opportunities provided digital technologies managing patients respiratory diseases